Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.

Why not use technology to find out what is going wrong on the factory floor – and why it is affecting supply chains?

Have you noticed a shortage of skilled individuals entering the pharma industry?

The Supreme Court will decide the fate of the abortion pill mifepristone in the US on March 26, 2024.

Why is the stable pools approach attracting more attention in the cell line development space?

As incidents of DEG poisoning continue to occur, the IPEC Federation issues a call for companies not to be complacent when it comes to supply chains.

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Self-propelled nanoparticles can reduce tumors in the bladder by 90 percent

The US Inflation Reduction Act continues to generate controversy as drugmakers make counteroffers.

A host of pharma industry experts discuss the increasing use of digital technology in decentralized clinical trials.